MaxCyte's (MXCT) Outperform Rating Reiterated at William Blair

William Blair reaffirmed their outperform rating on shares of MaxCyte (NASDAQ:MXCT – Free Report) in a report published on Tuesday morning, RTT News reports. Separately, Craig Hallum started coverage on MaxCyte in a research note on Wednesday, November 29th. They issued a buy rating and a $7.00 target price on the stock. View Our Latest […]

Related Keywords

United States , Canada , Craig Hallum , John Joseph Johnston , William Blair , Tower Research Capital , Royal Bank , Us Bancorp , Maxcyte Inc , Financial Services Group Inc , Free Report , Director John Joseph Johnston , Services Group , Research Capital , Get Free Report , Maxcyte Daily ,